机构:[1]National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu 610064, China.[2]College of Materials Science and Engineering, Sichuan University, Chengdu, 610065, China.[3]Max Bergmann Center of Biomaterials, Leibniz Institute of Polymer Research Dresden, Dresden 01069, Germany.[4]Department of Cardiovascular Medicine, Xi'an Central Hospital, Xi'an 710003, China.[5]Research Unit. of Minimally Invasive Treatment of Structural Heart-Disease, Chinese Academy of Medical Sciences (2021RU013), Chengdu, 610065, China.
Cell membrane coating has emerged as a promising strategy for the surface modification of biomaterials with biological membranes, serving as a cloak that can carry more functions. The cloaked biomaterials inherit diverse intrinsic biofunctions derived from different cell sources, including enhanced biocompatibility, immunity evasion, specific targeting capacity, and immune regulation of the regenerative microenvironment. The intrinsic characteristics of biomimicry and biointerfacing have demonstrated the versatility of cell membrane coating technology on a variety of biomaterials, thus, furthering the research into a wide range of biomedical applications and clinical translation. Here, the preparation of cell membrane coatings is emphasized, and different sizes of coated biomaterials from nanoscale to macroscale as well as the engineering strategies to introduce additional biofunctions are summarized. Subsequently, the utilization of biomimetic membrane-cloaked biomaterials in biomedical applications is discussed, including drug delivery, imaging and phototherapy, cancer immunotherapy, anti-infection and detoxification, and implant modification. In conclusion, the latest advancements in clinical and preclinical studies, along with the multiple benefits of cell membrane-coated nanoparticles (NPs) in biomimetic systems, are elucidated.
基金:
This work was financially supported by the National Natural
Science Foundation of China (32371401), CAMS Innovation
Fund for Medical Sciences (CIFMS) (No. 2021-12M-5- 013),
Traditional Chinese Medicine Inheritance and Innovation and
Key Scientific Research Projects for the Development of “Qin
Medicine” (Grant No.: 2021-01-ZZ-013), Key project
supported by scientific Research Fund of Xi’an Central
Hospital in 2024 (Grant No.: 2024ZD02) and Sichuan
Science and Technology Program (2023ZYD0115).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|1 区材料科学
小类|1 区化学:综合1 区材料科学:综合1 区纳米科技
最新[2025]版:
大类|1 区材料科学
小类|1 区化学:综合1 区材料科学:综合1 区纳米科技
第一作者:
第一作者机构:[1]National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu 610064, China.
共同第一作者:
通讯作者:
通讯机构:[1]National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu 610064, China.[4]Department of Cardiovascular Medicine, Xi'an Central Hospital, Xi'an 710003, China.[5]Research Unit. of Minimally Invasive Treatment of Structural Heart-Disease, Chinese Academy of Medical Sciences (2021RU013), Chengdu, 610065, China.
推荐引用方式(GB/T 7714):
An Yongqi,Ji Cheng,Zhang Hao,et al.Engineered Cell Membrane Coating Technologies for Biomedical Applications: From Nanoscale to Macroscale[J].ACS Nano.2025,doi:10.1021/acsnano.4c16280.
APA:
An Yongqi,Ji Cheng,Zhang Hao,Jiang Qing,Maitz Manfred F...&Wang Yunbing.(2025).Engineered Cell Membrane Coating Technologies for Biomedical Applications: From Nanoscale to Macroscale.ACS Nano,,
MLA:
An Yongqi,et al."Engineered Cell Membrane Coating Technologies for Biomedical Applications: From Nanoscale to Macroscale".ACS Nano .(2025)